Rituximab in the treatment of Sjögren's syndrome: is it the right or wrong drug?

H Bootsma, FGM Kroese… - Arthritis & Rheumatology, 2017 - search.ebscohost.com
The authors focus on the role of B cells in the pathogenesis of a heterogeneous disease
known as Sjögren's syndrome (SS). They discuss the effectiveness of a potent biologic …
被引用次数：23 相关文章

[引用][C] Rituximab in the Treatment of Sjögren's Syndrome: Is It the Right or Wrong Drug?

H Bootsma, FGM Kroese, A Vissink - Arthritis & Rheumatology …, 2017 - europepmc.org
Editorial: Rituximab in the Treatment of Sjögren's Syndrome: Is It the Right or Wrong Drug? -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

[引用][C] Rituximab in the treatment of Sjögren's syndrome: Is It the Right or Wrong Drug?

H Bootsma, FGM Kroese, A Vissink - Arthritis & Rheumatology, 2017 - research.rug.nl
Rituximab in the treatment of Sjögren's syndrome: Is It the Right or Wrong Drug? — the University
of Groningen research portal Skip to main navigation Skip to search Skip to main content the …

[引用][C] Rituximab in the Treatment of Sjögren's Syndrome: Is It the Right or Wrong Drug?

H Bootsma, FGM Kroese… - Arthritis & rheumatology …, 2017 - pubmed.ncbi.nlm.nih.gov

[引用][C] Rituximab in the Treatment of Sjögren's Syndrome: Is It the Right or Wrong Drug?

H Bootsma, FGM Kroese, A Vissink - Arthritis & Rheumatology, 2017 - Wiley Online Library
The presence of anti-SSA/Ro and/or anti-SSB/La autoantibodies, elevated plasma levels of
gamma globulins and rheumatoid factor (RF), higher expression levels of Bruton's tyrosine …